This contract expires in 321 days (Jul 31, 2027).
BANNER HEALTH - NULISA (A NOVEL PROTEOMIC LIQUID BIOPSY PLATFORM WITH ATTOMOLAR SENSITIVITY AND HIGH MULTIPLEXING) TESTING SERVICES TO IDENTIFY BIOMARKERS THAT PROVIDE INFORMATION ABOUT THE UNDERLYING MOLECULAR CHANGES ASSOCIATED WITH AD/ADRD.
Key Details
Description
NULISA (A NOVEL PROTEOMIC LIQUID BIOPSY PLATFORM WITH ATTOMOLAR SENSITIVITY AND HIGH MULTIPLEXING) TESTING SERVICES TO IDENTIFY BIOMARKERS THAT PROVIDE INFORMATION ABOUT THE UNDERLYING MOLECULAR CHANGES ASSOCIATED WITH AD/ADRD.
Context & Analysis
On Jun 24, 2026, Department of Health and Human Services obligated $2,332,200 to BANNER HEALTH for nulisa (a novel proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing) testing services to identify biomarkers that provide information about the underlying molecular chang…. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: competed under sap with 2 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in ROCKVILLE, MD. The contract is scheduled through Jul 31, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541380 — related awards are listed below.
Contractor Information
Similar Awards
WASTEWATER SURVEILLANCE TESTING
VERILY HEALTH INC.
$42.3M
INNOVATION FUNNEL FOR COVID-19 - VALIDATION CENTER
EMORY UNIVERSITY
$41.2M
STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
$38.8M
CENTRALIZED OMICS RESOURCE (CORE) YEAR 5
THE BROAD INSTITUTE, INC
$36.4M
NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - TASK AREAS 2, 3, AND 4 - 2024 TASK ORDER
THE BROAD INSTITUTE, INC
$24.5M
Stay Updated
Get notified about new opportunities matching your interests.